Medleader Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -26.40%
- Profit Growth 217.78%
- Ebitda 164.10%
- Net Worth 190.78%
- Total Assets 99.71%
About Medleader Laboratories
Medleader Laboratories Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 August 2019 (Five years and five months 6 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Praveena and Waasia serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300TN2019PTC131355
-
Company No.
131355
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Aug 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Medleader Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveena
|
Director | 29-Aug-2019 | Current |
|
Waasia Hussain
|
Director | 29-Aug-2019 | Current |
Financial Performance of Medleader Laboratories.
Medleader Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.4% decrease. The company also saw a substantial improvement in profitability, with a 217.78% increase in profit. The company's net worth Soared by an impressive increase of 190.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medleader Laboratories?
Unlock access to Medleader Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Mmrf Hospital AssociationPraveena . is a mutual person
-
Medgrand Lifesciences Llp
Waasia . is a mutual person
-
Anwars Patternmaster Llp
Waasia . is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medleader Laboratories?
Unlock and access historical data on people associated with Medleader Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medleader Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medleader Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.